DIPEPTIDYL PEPTIDASE-4 INHIBITOR HAS BENEFICIAL EFFECTS ON POST-MYOCARDIAL INFARCTION HEART IN DIABETIC MICE

被引：0
|
作者：
Kubota, Akihiko [1 ]
Hasegawa, Hiroshi [1 ]
Kameda, Yoshihito [1 ]
Yuka, Kobara [1 ]
Tadokoro, Hiroyuki [1 ]
Kobayashi, Yoshio [1 ]
Komuro, Issei [1 ]
Takano, Hiroyuki [1 ]
机构：
[1] Chiba Univ, Grad Sch Med, Dept Cardiovasc Med, Chiba, Japan
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2013年 / 61卷 / 10期
关键词：
D O I：
10.1016/S0735-1097(13)60596-3
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E596 / E596
页数：1
相关论文
共 50 条
  • [21] Genetic Deletion or Pharmacological Inhibition of Dipeptidyl Peptidase-4 Improves Cardiovascular Outcomes After Myocardial Infarction in Mice
    Sauve, Meghan
    Ban, Kiwon
    Momen, M. Abdul
    Zhou, Yu-Qing
    Henkelman, R. Mark
    Husain, Mansoor
    Drucker, Daniel J.
    DIABETES, 2010, 59 (04) : 1063 - 1073
  • [22] The Dipeptidyl Peptidase-4 Inhibitor Linagliptin Attenuates Inflammation and Accelerates Epithelialization in Wounds of Diabetic ob/ob Mice
    Schuermann, Christoph
    Linke, Andreas
    Engelmann-Pilger, Kerstin
    Steinmetz, Cornelia
    Mark, Michael
    Pfeilschifter, Josef
    Klein, Thomas
    Frank, Stefan
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2012, 342 (01): : 71 - 80
  • [23] Renoprotective Effect of Gemigliptin, a Dipeptidyl Peptidase-4 Inhibitor, in Streptozotocin-Induced Type 1 Diabetic Mice
    Jung, Gwon-Soo
    Jeon, Jae-Han
    Choe, Mi Sun
    Kim, Sung-Woo
    Lee, In-Kyu
    Kim, Mi-Kyung
    Park, Keun-Gyu
    DIABETES & METABOLISM JOURNAL, 2016, 40 (03) : 211 - 221
  • [24] Incident heart failure and myocardial infarction in sodium-glucose cotransporter-2 vs. dipeptidyl peptidase-4 inhibitor users
    Zhou, Jiandong
    Lee, Sharen
    Leung, Keith Sai Kit
    Wai, Abraham Ka Chung
    Liu, Tong
    Liu, Ying
    Chang, Dong
    Wong, Wing Tak
    Wong, Ian Chi Kei
    Cheung, Bernard Man Yung
    Zhang, Qingpeng
    Tse, Gary
    ESC HEART FAILURE, 2022, 9 (02): : 1388 - 1399
  • [25] Protective Effects of Gemigliptin, a Dipeptidyl Peptidase-4 Inhibitor, against Cisplatin-Induced Nephrotoxicity in Mice
    Choi, Seung Hee
    Leem, Jaechan
    Lee, In-Kyu
    MEDIATORS OF INFLAMMATION, 2017, 2017
  • [26] Dipeptidyl peptidase-4 inhibitor treatment could decrease chronic rhinosinusitis in diabetic patients
    Li, S. -Y.
    Chen, H. -H.
    Lai, C. -C.
    Lin, C. -L.
    Kao, C. -H.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2020, 113 (03) : 181 - 185
  • [27] Combination therapy with a dipeptidyl peptidase-4 inhibitor and a proton pump inhibitor restores normoglycaemia in non-obese diabetic mice
    Suarez-Pinzon, W. L.
    Cembrowski, G. S.
    Rabinovitch, A.
    DIABETOLOGIA, 2009, 52 (08) : 1680 - 1682
  • [28] Combination therapy with a dipeptidyl peptidase-4 inhibitor and a proton pump inhibitor restores normoglycaemia in non-obese diabetic mice
    W. L. Suarez-Pinzon
    G. S. Cembrowski
    A. Rabinovitch
    Diabetologia, 2009, 52 : 1680 - 1682
  • [29] Dipeptidyl peptidase-4 inhibitor improves cardiac function by attenuating adverse cardiac remodelling in rats with chronic myocardial infarction
    Inthachai, Tharnwimol
    Lekawanvijit, Suree
    Kumfu, Sirinart
    Apaijai, Nattayaporn
    Pongkan, Wanpitak
    Chattipakorn, Siriporn C.
    Chattipakorn, Nipon
    EXPERIMENTAL PHYSIOLOGY, 2015, 100 (06) : 667 - 679
  • [30] Effects of dipeptidyl peptidase-4 inhibition in vivo: Dipeptidyl peptidase-4 inhibitor/gut microbiome crosstalk suggests novel therapeutic options for diabetes management
    Yasuda, Takuma
    Harada, Norio
    Inagaki, Nobuya
    JOURNAL OF DIABETES INVESTIGATION, 2024, 15 (06) : 704 - 706
12345